HRT Financial LP filed 299 Form 4 transactions across 41 companies, with open-market purchases totaling $24.66 million against open-market sales of $21.64 million. That net buying bias of roughly $3 million is modest for a firm of this activity level, and the recent window shows a near split: 13 buys and 12 sells in the last stretch of filings.
The dominant position is USO, the United States Oil Fund. On September 14, HRT filed six separate open-market purchases in USO totaling $15.99 million, with individual trades ranging from $337,613 to $6.79 million. That followed a September 11 session where HRT both bought and sold USO, with purchases of $557,525 and $43,806 against sales of $6.87 million, $4.94 million, $28,074, and $15,380. The September 15 filing shows one USO sale of $195,805, leaving the recent direction as heavy accumulation followed by a small trim.
Elsewhere, HRT traded TNON (Tenon Medical) on September 9 and 10, buying $380,624 across four purchases and selling $538,644 across three sales, a net reduction. GIPR saw only small sales: $9,922 on September 14, $1,142 on September 11, and $127 on September 15. WHLR had a single $1,862 sale on September 10. The pattern is concentrated: USO absorbs the bulk of capital, while smaller positions in TNON, GIPR, and WHLR are being trimmed or held flat.
AI-assisted summary